Affiliation:
1. Basic Medical College, Anhui Medical University, Hefei 230032, China
2. College of Pharmacy, Anhui Medical University, Hefei 230032, China
Abstract
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic disease caused by the increased formation or reduced excretion of serum uric acid (SUA). Alterations in SUA homeostasis have been linked to a number of diseases, and hyperuricemia is the major etiologic factor of gout and has been correlated with metabolic syndrome, cardiovascular disease, diabetes, hypertension, and renal disease. Oxidative stress is usually defined as an imbalance between free radicals and antioxidants in our body and is considered to be one of the main causes of cell damage and the development of disease. Studies have demonstrated that hyperuricemia is closely related to the generation of reactive oxygen species (ROS). In the human body, xanthine oxidoreductase (XOR) catalyzes the oxidative hydroxylation of hypoxanthine to xanthine to uric acid, with the accompanying production of ROS. Therefore, XOR is considered a drug target for the treatment of hyperuricemia and gout. In this review, we discuss the mechanisms of uric acid transport and the development of hyperuricemia, emphasizing the role of oxidative stress in the occurrence and development of hyperuricemia. We also summarize recent advances and new discoveries in XOR inhibitors.
Funder
Postdoctoral Science Foundation of Anhui Province
Subject
Cell Biology,Ageing,General Medicine,Biochemistry
Reference160 articles.
1. Examen chemicum calculi urinarii;C. Scheele;Opuscula,1776
2. Synthese der Harnsäure;J. Horbaczewski;Monatshefte für Chemie,1882
3. Uric acid transport and disease
4. Regulation of uric acid metabolism and excretion
5. Gout
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献